Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sanjeev S. Katti"'
Autor:
Robin D. Rogers, Paula Berton, Steven P. Kelley, Rajkumar Kore, Pavankumar Aduri, Sanjeev S. Katti
Publikováno v:
ACS Catalysis. 7:7014-7028
Group IIIA halometallate ionic liquids (ILs) present fascinating properties for the field of catalysis, particularly through the ability to tune their Lewis acidity solely by changing the metal complex speciation. In this Review, we present a critica
Autor:
Michael R. Reardon, Edward R. Lee, Vitaly Nivorozhkin, Lynne Sole, Jin Zhao, Craig Siegel, Sanjeev S. Katti, Paul A. Konowicz, Rayomand H. Gimi, Jerome Green
Publikováno v:
Organic Process Research & Development. 19:576-581
A small molecule was under investigation as an inhibitor of glucosylceramide synthase (GCS) for potential use in Fabry disease. To support preclinical activities, a four-step synthesis was developed and used to prepared kilogram quantities of the dru
Autor:
Sanjeev S. Katti, Natarajan Venkateswaran, Suresh B. Iyengar, Parasuveera Uppara, Balasubrahmanyam Avvaru
Publikováno v:
Ultrasonics sonochemistry. 42
Technologies based on cavitation, produced by either ultrasound or hydrodynamic means, are part of growing literature for individual refinery unit processes. In this review, we have explained the mechanism through which these cavitation technologies
Autor:
André J. Bourque, Sanjeev S. Katti, Richard Silva, Edward R. Lee, Vitaly Nivorozhkin, Scott Clark, Christopher G.F. Cooper
Publikováno v:
Organic Process Research & Development. 16:1090-1097
An economic, scalable process for the production of glucosylceramide synthase (GCS) inhibitor 7 has been developed. Herein we report a three-step synthesis to aldehyde 4 with high yield and purity that employs the selective cleavage of an endocyclic
Publikováno v:
Chemical Engineering Communications. 194:849-858
GT 267-004 is a nonabsorbed, nonantibiotic, high molecular weight anionic polymer that is undergoing clinical evaluation as a Clostridium difficile toxin sequestrant. The active pharmaceutical ingredient (API) is a mixed salt form that consists of ap
Autor:
Sanjeev S. Katti
Publikováno v:
Chemical Engineering Communications. 194:194-204
GT 267-004 is a nonabsorbed, nonantibiotic, high molecular weight anionic polymer that is undergoing clinical evaluation as a Clostridium difficile toxin sequestrant. The API is a mixed salt form that consists of approximately 30 to 50% potassium and
Autor:
Sanjeev S. Katti, Quarderer George J
Publikováno v:
Polymer Engineering and Science. 33:564-572
The Dow process for producing perfluorinated ionomeric membranes includes several emulsion copolymerizations involving gaseous tetrafluoroethylene and a second liquid phase monomer. The choice of the organic phase monomer depends on the desired produ
Autor:
Sanjeev S. Katti
Publikováno v:
Chemical Engineering Science. 47:2125-2127
Publikováno v:
Industrial & Engineering Chemistry Research. 27:1767-1775
Publikováno v:
Industrial & Engineering Chemistry Process Design and Development. 25:618-626